Somerset Pharma expands generic portfolioSomerset Pharma is introducing six new generic products. Alembic releases generic EffexorGeneric Effexor is used for treating various mental health conditions. Novartis files lawsuit against FDA over generic Entresto The complaint follows the FDA granting permission to MSN Laboratories for an Entresto generic product. Dr. Reddy’s receives positive CHMP opinion from EMA for proposed rituximab biosimilar Rituximab is used to treat various cancers. FDA gives Amneal OK for potassium phosphates injection IV bags The drug is a phosphorus replacement product indicated to correct hypophosphatemia Alembic receives FDA OK for generic Prolixin Fluphenazine hydrochloride tablets are indicated in the management of manifestations of psychotic disorders. FDA gives Long Grove OK for generic Halaven Eribulin mesylate injection is a cancer medication. Report finds increase in specialty drug trend, spend Specialty drug spend and trend rose in 2023, per the latest PSG report. Sandoz launches biosimilar Pyzchiva in Europe Pyzchiva is approved for treatment of adults with plaque psoriasis, psoriatic arthritis, Crohn’s disease and in certain pediatric plaque psoriasis patients. Alembic launches generic Valium Injection Diazepam injection is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. First Previous 14 15 16 17 18 Next Last
